02:45 , Nov 13, 2014 |  BC Extra  |  Company News

Precision Therapeutics recaps, now Helomics

Oncology diagnostics play Helomics Corp. (Pittsburgh, Pa.) recapitalized with a $60 million investment from HealthCare Royalty Partners and changed its name from Precision Therapeutics Inc. The company also named as its new CEO Neil Campbell,...
07:00 , Sep 24, 2012 |  BioCentury  |  Strategy

Big data: Then and now

The early genomics pioneers awakened the biopharma industry to the value of capturing and using data to drive drug development. But both the pioneers and those who have followed agree the industry still has far...
07:00 , Apr 3, 2000 |  BioCentury  |  Strategy

Gemini: Snapping up SNPs

Gemini: Snapping up SNPs Gemini Genomics plc is looking to link up with SNP providers to demonstrate medically significant associations between human SNPs and risk factors for a range of common diseases. The clinical genomics...
08:00 , Mar 27, 2000 |  BioCentury  |  Tools & Techniques

Celera and the 'logic of biology'

As it races to complete and make public the raw human genome sequence, Celera Genomics Corp. recently has taken back-of-the-hand shots from academic competitors and their sympathizers in the White House and 10 Downing Street....
08:00 , Mar 20, 2000 |  BioCentury  |  Politics, Policy & Law

Sniping over SNPs

With the genomics sector increasingly under a microscope, even minor developments can get blown out of proportion, and it becomes harder to draw the line between straight science and maneuvering to get a political or...
08:00 , Mar 13, 2000 |  BioCentury  |  Strategy

No love letters lost

As the initial sequencing of the human genome enters its last days, it probably was inevitable that the urgency to claim credit and the imperative to make money would collide. Thus the airing of the...
08:00 , Jan 17, 2000 |  BC Week In Review  |  Company News

Axys, Celera Genomics Corp., Shanghai GeneCore Biotechnologies Co. Ltd. deal

PE Corp. (Norwalk, Conn.) business unit CRA acquired the 47.5 percent equity interest in genomics services company GeneCore that was formerly held by AXPH. PE Biosystems (PEB, Foster City, Calif.), another PE Corp. unit, also...
08:00 , Jan 10, 2000 |  BioCentury  |  Finance

Drilling down deeper

For the past two years, investors have made great returns in the top tier biotechs, driving them up 79 percent in 1998 and 53 percent in 1999. Now the rotation into companies with real products,...
07:00 , Oct 25, 1999 |  BC Week In Review  |  Company News

Celera Genomics Corp. other research news

CRA said that it has sequenced 1.2 billion bases of human genomic DNA since beginning its human genome sequencing efforts in September. The company also said that it has filed provisional patent applications on 6,500...
07:00 , Sep 13, 1999 |  BC Week In Review  |  Company News

Celera Genomics Corp. other research news

CRA said that it has completed the sequencing of the genome of Drosophila melanogaster, which the company began in May 1999. Computational assembly of the Drosophila sequence, consisting of 1.8 billion base pairs of genomic...